Global Medical REIT Inc.GMRE

時価総額

$23.5億

PER

医療施設の取得・賃貸を行うREITの有力企業。中長期トリプルネットリースと物件運営を展開。2024年に15物件取得、2024年1月に3億ドルATM導入、同年12月にHeitmanと87.5%/12.5%でJV形成。米国中心展開。

	2012年 8月31日	2013年 8月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日	2024年 12月31日
Net income	-50,108	-45,338	-	-	-	-	-	-	-	20	22	7
Depreciation, Total	-	-	659,671	2	8	14	19	27	34	40	41	40
Amortization of Leased Asset	-	-	-	-	-	-	6	10	13	17	17	14
Amortization of above market leases, net	-	-	-	-994	0	1	1	1	1	1	1	1
Amortization of Other Deferred Charges	-	-	-	-	-	-	1	1	2	2	2	2
Share-based Compensation	-	-	-	2	2	3	3	5	6	5	4	5
Noncash Merger Related Costs	-	-	-	-	0	0	0	0	0	0	0	0
Reserve for uncollectible accounts	-	-	-	-	-	-	-	1	0	-	1	1
Gain on sale of investment properties	-	-	-	-	-	-	-	-	1	7	16	4
Impairment of investment property	-	-	-	-	-	-	-	-	-	-	-	2
Equity loss from unconsolidated joint venture	-	-	-	-	-	-	-	-	-	-	-	0
Loss on extinguishment of debt	-	-	-	-	-	-	-	-	-	-	-1	-
Other	-	-	-	-	-	-	-0	0	-0	-0	-0	-0
Tenant receivables	-	-	-	212,435	0	2	2	2	1	3	-0	1
Deferred assets	-	-	-93,646	681,242	3	6	5	6	5	4	3	2
Other assets and liabilities	-	-	-	-	0	0	0	0	-0	-1	-1	-2
Accounts payable and accrued expenses	-	-	-	-39,509	1	2	1	2	2	4	-2	3
Security deposits	-	-	-	719,592	1	2	2	0	0	1	-2	-0
Net cash provided by operating activities	-35,108	-33,794	-208,801	-	12	25	36	35	69	77	68	70
Purchase of land, buildings, and other tangible and intangible assets and liabilities	-	-	-	150	252	181	255	218	192	151	0	82
Proceeds From Sale Of Investment Property	-	-	-	-	-	-	-	-	5	18	79	57
Investment in unconsolidated joint venture	-	-	-	-	-	-	-	-	-	-	-	2
Escrow deposits for purchase of properties	-	-	-	-104,310	0	-0	1	-0	-2	-0	-	0
Advances made to related parties	-	-	-	137,727	0	-0	-0	0	-0	-0	0	-0
Payment received on loan made to a tenant	-	-	-	-	-	-	-	-	-	1	-	-
Capital expenditures on existing real estate investments	-	-	-	-	-	-	-	-	-	-	-	13
Leasing commissions	-	-	-	-	-	-	-	-	-	-	1	6
Net cash used in investing activities	-	-	-32,338,990	-	-253	-152	-258	-224	-195	-137	68	-46
Proceeds from Issuance of Common Stock	55,000	80,000	-	-	34	37	189	53	206	10	-	11
Escrow deposits required by third party lenders	-	-	-	-	-	-	-	-	-	-	7	0
Repayment of notes payable	-	-	349,435	-	-	-	-	-	-	1	1	12
Payment for CMBS loan defeasance	-	-	-	-	-	-	-	-	-	-	32	-
Proceeds from Credit Facility	-	-	-	28	-	186	244	238	222	139	83	144
Repayment of Credit Facility	-	-	-	-	-	71	173	65	224	16	136	100
Payment of debt issuance costs	-	-	-	-	-	-	-	1	6	3	-	-
Dividends paid to common stockholders, and OP Unit and LTIP Unit holders	-	-	-	-	-	-	-	40	53	58	59	60
Dividends paid to preferred stockholders	-	-	-	4	1	6	6	6	6	6	6	6
Net cash provided by financing activities	55,380	80,380	41,643,255	-	226	125	224	193	128	62	-144	-22
Net (decrease) increase in cash and cash equivalents and restricted cash	-	-	-	-	-	-2	2	4	2	2	-8	2
Interest Paid, Net	-	-	1,165,157	4	6	13	16	17	18	22	30	27
Liabilities Assumed	-	-	-	4	6	7	11	12	16	16	16	17
Interest rate swap agreements fair value change recognized in other comprehensive income	-	-	-	-	-	-	-	12	-12	-41	10	7
Units Converted To Common Stock	-	-	-	-	-	-	-	18	1	1	0	1
Capital Expenditures Incurred but Not yet Paid	-	-	-	-	11	16	1	-	1	1	2	2
Stock Issued	-	-	-	30	-	-	-	-	-	-	5	-
Loans Assumed	-	-	-	-	-	-	-	12	-	2	-	-
Notes Reduction	-	-	-	-	-	-	-	-	-	-	0	-